1. Home
  2. SLNO vs NWE Comparison

SLNO vs NWE Comparison

Compare SLNO & NWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • NWE
  • Stock Information
  • Founded
  • SLNO 1999
  • NWE 1923
  • Country
  • SLNO United States
  • NWE United States
  • Employees
  • SLNO N/A
  • NWE N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • NWE Power Generation
  • Sector
  • SLNO Health Care
  • NWE Utilities
  • Exchange
  • SLNO Nasdaq
  • NWE Nasdaq
  • Market Cap
  • SLNO 3.8B
  • NWE 3.5B
  • IPO Year
  • SLNO 2014
  • NWE N/A
  • Fundamental
  • Price
  • SLNO $52.75
  • NWE $57.14
  • Analyst Decision
  • SLNO Strong Buy
  • NWE Buy
  • Analyst Count
  • SLNO 10
  • NWE 7
  • Target Price
  • SLNO $112.50
  • NWE $60.00
  • AVG Volume (30 Days)
  • SLNO 1.9M
  • NWE 493.3K
  • Earning Date
  • SLNO 11-05-2025
  • NWE 10-27-2025
  • Dividend Yield
  • SLNO N/A
  • NWE 4.62%
  • EPS Growth
  • SLNO N/A
  • NWE 7.14
  • EPS
  • SLNO N/A
  • NWE 3.67
  • Revenue
  • SLNO $32,656,999.00
  • NWE $1,527,970,000.00
  • Revenue This Year
  • SLNO N/A
  • NWE $6.15
  • Revenue Next Year
  • SLNO $175.39
  • NWE $4.73
  • P/E Ratio
  • SLNO N/A
  • NWE $15.56
  • Revenue Growth
  • SLNO N/A
  • NWE 3.78
  • 52 Week Low
  • SLNO $41.50
  • NWE $50.43
  • 52 Week High
  • SLNO $90.32
  • NWE $59.89
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 24.40
  • NWE 55.88
  • Support Level
  • SLNO $50.63
  • NWE $56.14
  • Resistance Level
  • SLNO $72.99
  • NWE $58.22
  • Average True Range (ATR)
  • SLNO 4.32
  • NWE 0.78
  • MACD
  • SLNO -1.06
  • NWE -0.22
  • Stochastic Oscillator
  • SLNO 9.34
  • NWE 45.04

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About NWE NorthWestern Energy Group Inc.

NorthWestern Energy Group Inc provides electricity and natural gas services in the Upper Midwest and Northwest of the U.S. in the states of Montana, South Dakota, Nebraska, and Yellowstone National Park. The company's primary segments include Electric utility operations, which include the generation, purchase, transmission, and distribution of electricity, and Natural Gas utility operations, which include the production, purchase, transmission, storage, and distribution of natural gas. The company uses thermal, wind, hydro, or renewable energy in varying quantities, depending on the location of the facilities, to generate power. The company derives the majority of its revenue from the Electric utility operations segment.

Share on Social Networks: